Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

GTBP holding history

GT Biopharma, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GTBP overviewAll 13F holders of GTBPFull Q2 2026 holdings

Shares (Q2 2026)
22,573
Value
$11.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GTBP by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,573$11.1K<0.1%+5,974+36.0%AddedHolders
Q1 202616,599$6.77K<0.1%−2,000−10.8%ReducedHolders
Q4 202518,599$14.6K<0.1%+4,584+32.7%AddedHolders
Q3 202514,015$8.22K<0.1%+10,000+249.1%AddedHolders
Q2 20254,015$14.4K<0.1%+482+13.6%AddedHolders
Q1 20253,533$7.60K<0.1%00.0%UnchangedHolders
Q4 20243,533$10.8K<0.1%+3,267+1,228.2%AddedHolders
Q3 2024266$614<0.1%00.0%UnchangedHolders
Q2 2024266$753<0.1%00.0%UnchangedHolders
Q1 2024266$1.18K<0.1%−3−1.2%ReducedConverted for a 1-for-30 splitHolders
Q4 20238,078$2.06K<0.1%00.0%UnchangedHolders
Q3 20238,078$1.95K<0.1%00.0%UnchangedHolders
Q2 20238,078$2.52K<0.1%00.0%UnchangedHolders
Q1 20238,078$4.44K<0.1%+267+3.4%AddedHolders
Q4 20227,811$6.92K<0.1%+4,246+119.1%AddedHolders
Q3 20223,565$5.00K<0.1%−130,478−97.3%ReducedHolders
Q2 2022134,043$400.0K<0.1%−132,871−49.8%ReducedHolders
Q1 2022266,914$768.0K<0.1%−175,880−39.7%ReducedHolders
Q4 2021442,794$1.35M<0.1%+190,503+75.5%AddedHolders
Q3 2021252,291$1.70M<0.1%+217,451+624.1%AddedHolders
Q2 202134,840$540.0K<0.1%+32,232+1,235.9%AddedHolders
Q1 20212,608$18.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.